# Safety Testing of Drug Metabolites - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/safety-testing-of-drug-metabolites/f87f3786-685f-4a28-963e-3499543cdd61

> FDA guidance document: Safety Testing of Drug Metabolites. Issue date: November 22, 2016. Get complete insights and analysis.

---

## Details

- Title: Safety Testing of Drug Metabolites
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2016-11-22
- Last Changed: 2020-04-30
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2008-D-0065">FDA-2008-D-0065</a>

## Related Documents

- [Nonclinical Testing of Orally Inhaled Nicotine-Containing Drug Products Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/nonclinical-testing-of-orally-inhaled-nicotine-containing-drug-products-guidance-for-industry/0ffdae5e-74df-4de2-b513-31064caf444d)
- [Vulvovaginal Candidiasis:  Developing Drugs for Treatment](https://www.globalkeysolutions.net/guidances/guidance-document/vulvovaginal-candidiasis-developing-drugs-for-treatment/3c14a50c-15d0-4ad3-94ec-76a32afa2bdb)
- [Osteoporosis:  Nonclinical Evaluation of Drugs Intended for Treatment Guidance for Industry:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/osteoporosis-nonclinical-evaluation-of-drugs-intended-for-treatment-guidance-for-industry-guidance-for-industry/8305ef9e-7edf-412b-bb46-28ef3a7f9493)